Type your tag names separated by a space and hit enter

Q Fever

Q Fever is a topic covered in the 5-Minute Clinical Consult.

To view the entire topic, please or purchase a subscription.

Medicine Central™ is a quick-consult mobile and web resource that includes diagnosis, treatment, medications, and follow-up information on over 700 diseases and disorders, providing fast answers—anytime, anywhere. Explore these free sample topics:

Medicine Central

-- The first section of this topic is shown below --

Basics

Description

Zoonotic disease caused by Coxiella burnetii, a hearty organism that can survive for years in soil

  • Infected animals are usually asymptomatic, although repeated pregnancy losses can occur.
  • Infection in humans results in illness ranging from mild symptomatology to chronic disease.

Epidemiology

  • Endemic worldwide except in New Zealand
    • Point-source outbreaks also occur.
  • Primary reservoirs are farm animals (cattle, goats, sheep) and urban pets (dogs, cats, rabbits) (1).
  • Environmental reservoirs are wild animals: mammals, birds, reptiles, and ticks. Ticks may act as vectors but are not a necessary link in transmission (1).
  • Acanthamoeba castellanii may also be a reservoir (1).
  • The highest concentration of C. burnetii is present in products of conception (amniotic fluid and placenta):
    • Also excreted in urine, feces, and milk
  • Transmission
    • Typically inhalation of infected aerosol droplets: infected barnyard dust, air conditioning (1)
    • Consumption of unpasteurized dairy products
    • Percutaneous exposure
    • Human-to-human transmission: Infected parturient women, sexual intercourse, fomite transmission, transplacental transmission, tick bites, blood transfusion, and bone marrow transplantation are other means of transmission.

Incidence
  • United States
    • 0.28 cases per million per year (2)
    • Reported cases in every state; >50% from seven states where livestock farming is common (2,3)
      • California, Colorado, Illinois, Kentucky, Missouri, Tennessee, Texas
  • Worldwide
    • Largest reported outbreak of Q fever was in the Netherlands from 2007 to 2010.
  • Incidence increases with age; 5 times more likely to occur in patients >15 years
  • Male > female (2.5:1); males more often symptomatic

Prevalence
Estimated seroprevalence in the United States is 3% in healthy adults and 10–20% in high-risk occupations. Q fever is underdiagnosed and underreported (2).

Etiology and Pathophysiology

  • C. burnetii is an obligate intracellular bacterium with a pleomorphic membrane akin to gram-negative bacteria; prefers mononuclear phagocytes but can infect other cell lines (3)
    • Resistance to heat, drying, and disinfectants allows organism to survive and promotes environmental spread. This makes source identification difficult.
    • Highly infectious, one organism sufficient to cause disease
    • Class B bioterrorism agent
    • Incubation period is 1 to 3 weeks (1).
  • Clinically relevant antigenic variation
    • Phase I (wild type); virulent natural phase found in infected animals and humans. In chronic Q fever infection, phase I antibodies are higher.
    • Phase II is less infectious in immunocompetent mammals and is typically found after laboratory processing. Antibodies to phase II are higher in acute Q fever infection.
  • C. burnetii in nonimmune persons causes:
    • Asymptomatic infection (60%)
    • Mild illness (36–38%)
    • Severe illness and hospitalization (2–4%) (4)
  • Acute Q fever with mild illness
    • Self-limited flulike illness that resolves after 1 to 3 weeks and is often undiagnosed
  • Acute Q fever with severe illness
    • Presents as atypical pneumonia, encephalitis, aseptic meningitis, prolonged fever of unknown origin, myocarditis, pericarditis, or hepatitis
    • Pneumonia is more likely in older patients, can last up to 90 days; often mistaken as viral
    • Hepatitis is more common in younger patients and is a granulomatous process.
    • Rare: hemolytic or hypoplastic anemia, orchitis, thyroiditis, pancreatitis (inappropriate secretion of antidiuretic hormone [SIADH]), glomerulonephritis, bone marrow necrosis, acalculous cholecystitis, panniculitis, splenic rupture, or epididymitis (4)
  • Post-Q fever fatigue syndrome: occurs in 20% of patients with acute Q fever. Patients have symptoms for >1 year, elevated antibody titres, and lack of clinical and laboratory evidence for chronic Q fever (3).
  • Chronic Q fever is defined as infection lasting >6 months. It may develop months or years after the initial infection in a vulnerable host:
    • Affects 1–5% of persons with acute Q fever
    • Most common manifestation is endocarditis (60–70%). Less common manifestations include osteomyelitis, vascular aneurysms, prosthetic infections, pulmonary interstitial fibrosis, pericardial effusion, pulmonary pseudotumor, lymphoma-like illness, amyloidosis, and mixed cryoglobulinemia (4).

Genetics
Genetic factors do not influence clinical course.

Risk Factors

  • Occupational: farmers, abattoir (slaughterhouse) workers, veterinarians, or other animal handlers; laboratory personnel, and people handling unpasteurized dairy products, wool, or animal hides
  • Living in a rural area within 10 miles of a farm with cattle, sheep, or goats (3)
  • Recent travel/military service in areas of higher risk (agricultural communities, Netherlands, Middle East)
  • Tobacco smoking (1)
  • Consumption of raw milk
  • Risk for progression from acute to chronic Q fever is seen with increased age, preexisting valvular heart disease, prosthetic joints, and immunocompromise.

Pediatric Considerations
Often a self-limited, milder acute illness; chronic Q fever is rare. GI symptoms in 50–80%; skin rash in 50% (3)

Pregnancy Considerations
Q fever in the 1st trimester increases risk of chronic Q fever and obstetric complications.

General Prevention

Vaccine is not commercially available in the United States:

  • Registered in Australia and given to abattoir workers
  • Efficacious in specific populations; duration of immunogenicity is uncertain (5).

-- To view the remaining sections of this topic, please or purchase a subscription --

Citation

Stephens, Mark B., et al., editors. "Q Fever." 5-Minute Clinical Consult, 27th ed., Wolters Kluwer, 2019. Medicine Central, im.unboundmedicine.com/medicine/view/5-Minute-Clinical-Consult/816102/all/Q_Fever.
Q Fever. In: Stephens MB, Golding J, Baldor RA, et al, eds. 5-Minute Clinical Consult. 27th ed. Wolters Kluwer; 2019. https://im.unboundmedicine.com/medicine/view/5-Minute-Clinical-Consult/816102/all/Q_Fever. Accessed April 19, 2019.
Q Fever. (2019). In Stephens, M. B., Golding, J., Baldor, R. A., & Domino, F. J. (Eds.), 5-Minute Clinical Consult. Available from https://im.unboundmedicine.com/medicine/view/5-Minute-Clinical-Consult/816102/all/Q_Fever
Q Fever [Internet]. In: Stephens MB, Golding J, Baldor RA, Domino FJ, editors. 5-Minute Clinical Consult. Wolters Kluwer; 2019. [cited 2019 April 19]. Available from: https://im.unboundmedicine.com/medicine/view/5-Minute-Clinical-Consult/816102/all/Q_Fever.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC T1 - Q Fever ID - 816102 ED - Stephens,Mark B, ED - Golding,Jeremy, ED - Baldor,Robert A, ED - Domino,Frank J, BT - 5-Minute Clinical Consult, Updating UR - https://im.unboundmedicine.com/medicine/view/5-Minute-Clinical-Consult/816102/all/Q_Fever PB - Wolters Kluwer ET - 27 DB - Medicine Central DP - Unbound Medicine ER -